The chromosomal inversion 16(p13;q22) associated with human acute myeloid leukemia generates the chimeric PEBP2b/CBFb-SMMHC gene. The PEBP2b/CBFb portion of the chimeric polypeptide harbors most of the amino acid sequence of the PEBP2b/CBFb protein, the non-DNA binding subunit of the heterodimeric transcription factor, PEBP2/CBF, whereas the SMMHC portion of the chimera consists of the rod domain of the smooth muscle myosin heavy chain molecule. In this study we examined the subcellular localization of the chimeric protein and its eect both on stress ®bers and transcriptional activation by transfecting cDNA into tissue culture cells. The localization of the chimera was investigated by immunocytochemical staining of cells and was found to be both cytoplasmic and nuclear. One aspect of the eect of expression of the chimera was a drastic alteration of cell morphology. The cells appeared elongated and possessed long cytoplasmic processes. Double¯uorescent labeling revealed disorganization of the stress ®bers and an altered F-actin staining pattern in the transfected cells. Studies using a deletion mutant showed that both the PEBP2b/CBFb and SMMHC domains are necessary for the induction of the morphological alteration. A signi®cant proportion of the chimeric protein was retained in the cytoskeleton after detergent extraction of the cells and could be recuperated as a membrane fraction, suggesting that this is one of the probable sites of action of the PEBP2b/ CBFb-SMMHC protein. Another eect of the chimeric protein was inhibition of transcriptional activation dependent on the PEBP2/CBF binding DNA sequence. However, deregulation of PEBP2/CBF site dependent transcription by itself was not sucient to induce cell morphological changes. Taken together, these results indicate that the PEBP2b/CBFb-SMMHC chimeric protein acts at two levels, at the level of stress ®ber organization and at the level of transcriptional activation. We suggest that the action of PEBP2b/CBFb-SMMHC depends to a great extent on whether it is located in the cytoplasm or in the nucleus.
Introduction
The cytogenetical basis of human acute myeloid leukemia (AML) is generally accepted to be the outcome of chromosomal rearrangements that result in the generation of chimeric genes encoding the activated oncogenes. The genes encoding the heterodimeric transcription factor, PEBP2/CBF, are the most frequent targets of chromosomal rearrangements seen in human AML (reviewed by Ito, 1996; Liu et al., 1995; Nucifora and Rowley, 1995) . The AML1/ Pebpa2b/Cbfa2 gene encodes a DNA-binding protein, the a subunit of PEBP2/CBF (Bae et al., 1993 Kagoshima et al., 1993; Meyers et al., 1993; Ogawa et al., 1993b) , and is rearranged in several types of chromosomal translocations (Erickson et al., 1992; Golub et al., 1995; Mitani et al., 1994; Miyoshi et al., 1991 Miyoshi et al., , 1993 Nucifora et al., 1993; Romana et al., 1995; Shurtle et al., 1995) . For example, in the chromosomal translocation t(8;21)(q22;q22), which is associated with the M2 subtype of AML, AML1 is fused in frame to another gene, MTG8/ETO (Erickson et al., 1992; Miyoshi et al., 1993) . On the other hand, inversion of chromosome 16, which is associated with the M4-eosinophilia subtype of AML, involves the Pebpb2/ Cbfb gene (Claxton et al., 1994; Liu et al., 1993) encoding the non DNA-binding, b subunit of PEBP2/ CBF (Ogawa et al., 1993a; Wang et al., 1993) . The AML1/Pebpa2b/Cbfa2 and Pebpb2/Cbfb genes, not only by virtue of their involvement in human AML, play an essential role in physiological hematopoiesis as was shown by recent gene targeting studies. Targeting of either AML1/Pebpa2b/Cbfa2 (Okuda et al., 1996; Wang et al., 1996a) or Pebpb2/Cbfb Sasaki et al., 1996; Wang et al., 1996b) led to almost identical phenotypes in developing mice embryos, namely, failure to generate de®nitive hematopoiesis in the fetal liver with concomitant, massive hemorrhaging in the central nervous system. Thus, the a and b subunits of PEBP2/CBF function together as one entity, a heterodimer, inside cells and tissues.
In inv16(p13;q22), a chimeric gene is generated between Pebpb2/Cbfb and the smooth muscle myosin heavy chain (SMMHC, MYH11) genes (Claxton et al., 1994; Liu et al., 1993) . The in-frame fused chimeric transcript encodes the PEBP2b/CBFb-SMMHC polypeptide (see Figure 1) . A carboxy-terminal portion of the chimera contains the rod domain of the myosin heavy chain molecule which is responsible for the molecule's oligomerization (Kiehart, 1990 ). An aminoterminal portion of the chimera harbors most of the amino acid sequence of the PEBP2b/CBFb protein, and the chimeric polypeptide itself has been shown to retain the ability to interact with the a subunit of PEBP2/CBF (Cao et al., 1997; Liu et al., 1994 Liu et al., , 1996 . It is also reported that the chimeric protein can deregulate PEBP2/CBF site dependent transcriptional activation in transient expression assays . Furthermore, a knocking-in study, which resulted in mice heterozygous for the chimeric allele, Pebpb2/Cbfb-SMMHC/+, revealed a phenotype similar to that seen after targeting of Pebpb2/Cbfb or AML1/Pebpa2b/Cbfa2 (Castilla et al., 1996) . This observation clearly demonstrates that the chimeric PEBP2b/CBFb-SMMHC protein can function in a dominant negative fashion over the PEBP2/CBF transcription factor. So far, the activity of the chimeric protein has only been analysed with respect to its interaction with the a subunit of PEBP2/CBF.
On the other hand, we have reported several observations indicating that the prototype PEBP2b/ CBFb protein displays additional features other than those associated with its role as a subunit of a transcription factor. In tissue culture cells, the endogenous or exogenously expressed PEBP2b/CBFb is located mainly in the cytoplasm, where it is free from the a subunit (Lu et al., 1995; Tanaka et al., 1997) . In addition, throughout the dierentiation stages of skeletal myogenic cells in mouse embryos, the endogenous PEBP2b/CBFb protein is mostly detected in the cytoplasm . This cytoplasmic PEBP2b/CBFb appears to have some degree of anity for cytoskeletal structures. On cytoskeleton preparations of tissue culture cells, a fraction of PEBP2b/ CBFb colocalizes with F-actin containing stress ®bers and with vinculin in the membrane rues . Double immunolabeling of PEBP2b/CBFb and a-actinin also reveals their colocalization on, or in the vicinity of the Z-lines of the skeletal muscle ®ber of adult mice . Thus, PEBP2b/CBFb should also be considered a cytoplasmic and cytoskeleton-anity protein as well as a nuclear protein.
As for the PEBP2b/CBFb-SMMHC chimeric protein, its subcellular localization appears to be either cytoplasmic and/or nuclear, depending on the experimental conditions employed in each report (Cao et al., 1997; Liu et al., 1996; Lu et al., 1995; Wijmenga et al., 1996) . In order to extend our previous observations on the cytoskeleton-anity of the PEBP2b/CBFb protein , we have focused one part of the present study on the possible eects of the cytoplasmic PEBP2b/CBFb-SMMHC protein on cell morphology and F-actin containing stress ®bers. We show that a signi®cant amount of the overexpressed chimera can be recovered in the cytoskeleton and membrane fraction of tissue cultured cells, and that the stress ®bers are disorganized in such cells with an accompanying alteration in the F-actin staining pattern. The other part of this study deals with the part of the chimeric protein located in the nucleus, and con®rms the inhibitory eect of the chimera on PEBP2/CBF dependent transcription. We show, however, that deregulation of PEBP2/CBF dependent transcription by itself does not necessarily cause a morphological alteration of the cells. Thus, we propose that the PEBP2b/CBFb-SMMHC chimeric protein behaves as a bifunctional protein, whose precise action is determined by its subcellular localization. The mechanism that underlies this unique property is discussed in relation to the characteristic structural features of the chimeric protein.
Results
Eect of the chimeric protein on cell morphology and stress ®bers
In order to detect the expression of the exogenously introduced chimeric cDNA easily, we added the hemagglutinin (HA) epitope of¯uvirus to the aminoterminus of the chimeric protein (Figure 1) . The HAPEBP2b-SMMHC plasmid was transfected into C2C12 mouse myoblasts because of their high transfection eciency. Protein was extracted from the transfected cells, gel electrophoresed and processed for immunoblot analysis, using an anti-HA monoclonal antibody (see lane 1, Figure 2 ). A single band was detected at 75 kilodaltons, con®rming that the chimeric protein had been synthesized correctly from the transfected cDNA. Unexpectedly, after the cells were ®xed and immunocytochemically stained with the antibody described above, the HA-positive cells appeared irregular and elongated in shape and possessed long processes of the cytoplasm (Figure 3a) . In contrast, the morphology of the HA-negative cells was indistinguishable from that of untransfected cells. Therefore, expression of the chimeric HA-PEBP2b-SMMHC protein caused drastic alterations in cellular morphology. The morphological changes of the cDNA-transfected cells, however, were observed not only in this cell line but also in NIH3T3 ®broblasts, rat embryo ®broblasts (REF) 52 and P19 embryonal carcinoma cells (data not shown), indicating that the observed phenomena are not only restricted to C2C12 cells.
We next examined which regions of the chimeric protein were responsible for the induction of the cell morphological changes. An internal deletion mutant, HA-DPEBP2b-SMMHC, was constructed as shown in Figure 1 . The polypeptide expressed by this plasmid lacks the region spanning the amino acid 5 ± 141 of the PEBP2b/CBFb protein. This region was previously shown to be necessary for PEBP2b/CBFb dimerization with the a subunit of PEBP2/CBF (Kagoshima et al., 1996; Ogawa et al., 1993a) . When the deletion mutant was transfected into the cells, a single band was detected in the protein extract at the expected size by immunoblot analysis (Figure 2 , lane 2). In immunocytochemical staining, the morphology of the HApositive cells expressing the mutated polypeptide was indistinguishable from that of the untransfected cells (Figure 3b ). The exogenously expressed PEBP2b/CBFb protein by itself did not cause any morphological changes in C2C12 cells (data not shown) as we showed previously for REF52 cells . These results indicate that neither the PEBP2b/CBFb protein alone nor the rod domain of the myosin heavy chain molecule are not sucient to induce cell morphological changes. Rather, both of the domains must be fused for the chimeric protein to exert morphological changes. Transfection of the cells with a plasmid expressing the PEBP2b/CBFb-SMMHC protein without the HA tag induced similar morphological alterations (data not shown).
As far as the subcellular localization of the HAPEBP2b/CBFb-SMMHC chimeric polypeptide is concerned, most of the HA staining was detected in the cytoplasm (Figure 3a) . The staining was positive even for the tips of the long cytoplasmic processes. It must be noted that some, weaker staining was also observed in the nuclei of transfected cells. In the case of cells transfected with the deletion mutant, staining was detected in the cytoplasm (Figure 3b ). Condensation of staining into multiple granular structures was characteristic of this mutant, although the structural basis of this eect is unclear at present.
The morphological alterations suggest that expression of the chimeric polypeptide aects the organization of F-actin containing stress ®bers. Doublē uorescent labeling was performed on the HAPEBP2b-SMMHC transfected cells, where the chimeric protein was detected by the¯uorescein isothiocyanate (FITC)-conjugated secondary antibody ( Figure 4a ) and the F-actin by rhodamine isothiocyanate (RITC)-conjugated phalloidin ( Figure 4b ). Figure  4c shows a composite image of the¯uorescence from FITC and RITC, allowing the orientation of each cell to be easily identi®ed. The morphology of the chimeraexpressing cells was altered as described above ( Figure  4a ). The F-actin staining in the HA-positive cells (indicated by arrowheads in Figure 4b ) displayed the following characteristics: (1) Stress ®bers appeared not to be well developed; (2) F-actin in the cytoplasm sometimes appeared in the form of irregular, aggregated staining spots; (3) F-actin staining was detected along the membranes of long cytoplasmic processes and even as far out as their tips. The results shown in Figure 4 indicate that cell morphological changes induced by the chimeric protein are accompanied by disorganization of stress ®bers as well as alterations in the pattern of F-actin staining. Retention of the chimeric protein in the cytoskeleton preparation and in the membrane fraction
The results presented so far suggest that the PEBP2b/ CBFb-SMMHC chimeric protein somehow interacts with the cytoskeletal structure, thereby causing its disorganization. We examined this possibility by fractionating the cells and identifying the subcellular localization of the chimera. The transfected cells were extracted with a detergent, namely 0.1% (vol/vol) Nonidet P-40 (NP-40), in a microtubule-stabilizing buer. The detergent-resistant cytoskeleton preparation was ®xed and double labeled ( Figure 5 ). Thē uorescence from the chimeric protein was found to be retained in the cytoskeleton ( Figure 5a ) and disorganization of the stress ®bers was evident ( Figure 5b ). In contrast, well-developed stress ®bers were retained in the cytoskeleton of the cells not expressing the chimera.
In order to compare the relative amounts of the chimeric protein in the dierent cell fractions, an amount of protein corresponding to an equivalent number of cells was extracted from the cytoskeletal and soluble fractions, subjected to gel electrophoresis and processed for immunoblot analysis (Figure 6 ). The use of the anti-HA antibody revealed that most of the chimeric protein was recovered in the cytoskeleton fraction (indicated by an arrow in Figure 6a ). This was also con®rmed by the use of the anti-PEBP2b peptide antibody (compare lanes 5 and 6). Several bands indicated by a bracket are most likely proteolytic products of the chimera generated during the extraction procedure. Interestingly, the endogenous PEBP2b/CBFb protein, which migrated at 23 kilodalton (indicated by an arrowhead), was also mostly recovered in the cytoskeleton fraction. We also observed that the endogenous PEBP2b/CBFb protein in the untransfected cells was retained in the cytoskeleton fraction (lane 4). Therefore, the above results demonstrate that the chimeric protein as well as the endogenous PEBP2b/CBFb protein behave as cytoskeleton-anity proteins (see Tanaka et al., also as for the cytoskeleton-anitive PEBP2b/CBFb).
The chimeric protein in the cytoplasm was not homogenously distributed but appeared to be condensed in the membrane periphery of the morphologically altered cells (Figure 4a ). This tendency was more apparent for the chimeric protein stained on the cytoskeleton preparation (Figure 5a ). We therefore examined if the chimeric protein could be recuperated in the physically isolated membrane fraction. The cells transfected by HA-PEBP2b-SMMHC cDNA were homogenized in hypotonic buer and fractionated into cytosolic, membrane and nuclear fractions by dierential centrifugation. An amount of protein corresponding to an equivalent number of cells for each fraction was gel electrophoresed and processed for immunoblot analysis (Figure 7 ). The chimeric protein as revealed by the anti-HA antibody was much more present in the membrane fraction (lane 2) than in the cytosolic or nuclear fractions (lanes 1 and 3) . On the other hand, the endogenous PEBP2b/CBFb protein as revealed by the anti-PEBP2b peptide antibody was more distributed in the cytosolic and nuclear than in the membrane fractions (lanes 4, 5 and 6). The membrane location of the chimeric protein may provide an explanation for its eect on the F-actin distribution pattern as discussed below.
Eect of the chimeric proteins on PEBP2/CBF site dependent transcription
The chimeric protein was detected in the nucleus in addition to the cytoplasm by immunostaining ( Figure  3a) . We therefore explored the possibility that the CAT activity. The eect of the chimeric protein on PEBP2/CBF dependent transcription was also examined using P19 cells. This cell line displayed a relatively low CAT activity when transfected by the reporter plasmid alone (Figure 8b ), re¯ecting its low endogenous PEBP2/CBF-DNA binding activity . Indeed, cotransfection with the AML1b/ PEBP2aB1 expression plasmid yielded high CAT activity. However, here again, CAT activity was greatly reduced if the HA-PEBP2b-SMMHC expression vector was added to cotransfection assays containing the AML1b/PEBP2aB1 expression plas- The AML1-MTG8 protein generated by t(8;21)(q22;q22) retains the Runt domain of AML1 that is responsible for PEBP2/CBF site DNA binding . Due to replacement of the carboxy-terminal transactivation domain of AML1 with the MTG8-derived polypeptide, this chimeric protein also can deregulate PEBP2/CBF site dependent transcription (Frank et al., 1995; Lenny et al., 1995; Meyers et al., 1995) . We con®rmed that AML1-MTG8 can deregulate transcription in both C2C12 and P19 cells (Figure 8) . Thus, as far as deregulation of transcription is concerned, both the PEBP2b/CBFb-SMMHC and AML1-MTG8 chimeric proteins would appear to be equally functional. In the cotransfection experiments in Figure 8 , the pRSV-bGAL plasmid was included as a reference. The b-galactosidase activity measured for the cell extracts did not vary in the presence or absence of each of the two types of chimeric protein (data not shown). This indicates that deregulation of transcription by each chimeric protein is dependent on the PEBP2/CBF binding sequence of the reporter plasmid.
In contrast to PEBP2b/CBFb-SMMHC, however, the subcellular location of AML1-MTG8 was entirely nuclear as reported previously (Sacchi et al., 1996) and AML1-MTG8 expressing cells appeared not to suer from morphological alterations, as shown in Figure 9 . The AML1-MTG8 protein overexpressed in C2C12 cells was detected by an anti-AML1 antiserum. Therefore, the fact that the two chimeric proteins, PEBP2b/CBFb-SMMHC and AML1-MTG8, are comparable with respect to their eect on transcriptional activation but are dierent with respect to their cellular locations argues against the notion that deregulation of PEBP2/CBF site dependent transcription underlies the observed cell morphological alterations.
Discussion

Disorganization of stress ®bers by PEBP2b/CBFb-SMMHC
In this study we showed that expression of the chimeric PEBP2b/CBFb-SMMHC protein induces morphological alterations of tissue culture cells and that this alteration involves disorganization of stress ®bers and changes of F-actin staining. Both the PEBP2b/CBFb and SMMHC portions of the chimera were necessary to exert an eect on cell morphology, since neither the PEBP2b/CBFb protein alone nor the SMMHC portion of the chimera, represented by the internal deletion mutant, HA-DPEBP2b-SMMHC, showed any apparent eect. In this respect it is interesting to note that both of these domains of the chimera display cytoskeleton-anity. On the one hand, the SMMHC portion of the chimera represents the rod domain of myosin heavy chain. The staining pattern of HA-DPEBP2b-SMMHC was not homogenously diuse in the cytoplasm but showed multiple aggregates. These structures may be related to the oligomerizing ability of the rod domain (Kiehart, 1990) . As far as the PEBP2b/CBFb protein is concerned, we reported previously that a fraction of this protein colocalizes with stress ®bers in tissue culture cells . A region in PEBP2b/CBFb also shows a moderate degree of homology to some cytoskeletal proteins (unpublished observation). Therefore, it may not be so unreasonable to suggest that the chimeric polypeptide If so, the alterations in cell morphology and stress ®bers may be attributable to the direct action of the chimera on the cytoskeleton. In accordance with such a possibility, we observed that most of the chimeric protein was retained in the detergent-resistant cytoskeleton fraction. At the moment there exists no molecular mechanism to explain how the PEBP2b/CBFb-SMMHC chimeric protein causes disorganization of stress ®bers. It is worth noting that the chimeric protein in the cytoplasm was not homogenously distributed but appeared to be condensed in the membrane periphery of the morphologically altered cells. Furthermore, we demonstrated that a signi®cant amount of the chimeric protein could be recovered in the physically isolated cell membrane fraction. This observation suggests that the chimeric protein located in the membrane inhibits the anchoring of stress ®bers to the cell periphery, thereby, leading to an eventual disorganization of the stress ®bers. The molecular target of the inv 16-derived chimera in the membranecytoskeletal structures remains to be elucidated. One possible candidate molecule could be a member of the Ras and Rho family of proteins and its binding protein (reviewed by Aelst and D'Souza-Schorey, 1997). The Rho protein, for example, enhances the formation of stress ®bers and focal adhesions by activating Rho-regulated kinases Hall, 1992, 1994) . Expression of a dominant negative form of the Rho kinase, on the other hand, induces disassembly of stress ®bers and focal adhesion complexes (Amano et al., 1997; Leung et al., 1996) . Among the leukemic proteins, Bcr-Abl generated by t(9;22) in chronic myeloid leukemia is known to enhance phosphorylation of focal adhesion proteins (Salgia et al., 1995) .
Deregulation of transcription by PEBP2b/CBFb-SMMHC
It is known that the chimeric PEBP2b/CBFb-SMMHC protein interferes with PEBP2/CBF site dependent transcription in transient expression assays . We con®rmed this result by measuring transcriptional activation with both the exogenously and endogenously produced PEBP2a/CBFa protein. The PEBP2b/CBFb portion of the chimera retains the domain of PEBP2b/CBFb that is necessary for dimerization with the a subunit of PEBP2/CBF . As suggested, deregulation of transcription is likely to be mediated through an abnormal interaction of the chimeric protein with the a subunit protein (Liu et al., , 1995 . A prerequisite for the chimeric protein to deregulate transcription would be its location in the nucleus, although it can not be excluded that the cytoplasmic-located chimera prevents correct transportation of the newly synthesized a subunit protein from the cytoplasm into the nucleus. In fact, we observed that the chimera was detected in the nuclei of transfected cells and that the chimera interfered with transcription activated by the endogenous PEBP2/CBF. Thus, a favorable interpretation would be that at least some of the chimera functions in the nucleus, as far as transcriptional deregulation is concerned.
Dual functions of PEBP2b/CBFb-SMMHC
The (AML1-MTG8/ETO/+) heterozygous mouse embryos generated by a knocking-in strategy displayed a phenotype similar to that of the (Pebpb2/ Cbfb-SMMHC/+) heterozygote (Castilla et al., 1996; Yergeau et al., 1997) , indicating that these two chimeric proteins are equivalent in terms of their ability to abolish a function of the PEBP2/CBF transcription factor. Indeed, we con®rmed previous reports showing that the AML1-MTG8 chimeric protein also interferes with PEBP2/CBF dependent transcription (Frank et al., 1995; Lenny et al., 1995; Meyers et al., 1995) . It is noteworthy in this study that no morphological alteration was apparent in the AML1-MTG8 overexpressing cells and that its subcellular location was entirely nuclear. It is likely, therefore, that deregulation of PEBP2/CBF dependent transcription by itself does not necessarily result in the morphological changes associated with the PEBP2b/ CBFb-SMMHC chimera. Thus, it seems likely that the cytoplasmic and nuclear located PEBP2b/CBFb-SMMHC chimera exerts distinct eects on dierent target molecules, and that the morphological and transcriptional functions are mutually independent. In support of this suggestion, we recently isolated several independent subclones of P19 cells expressing the PEBP2b/CBFb-SMMHC protein. Most of the clones were found to express the chimera exclusively in the nuclei, whereas one clone expressed it predominantly in the cytoplasm. The cell morphological alterations described in the present study were only peculiar to the latter P19 clone expressing the chimera in the cytoplasm. All of the other clones with the nuclear expressing PEBP2b/CBFb-SMMHC protein were negative in this respect (unpublished results).
The t(3;21)(q26.2;q22) translocation associated with secondary leukemia results in the generation of AML1-EVI1 chimeric protein which is known to in¯uence both the PEBP2/CBF and AP1 sites dependent transcription (Tanaka et al., 1995) . The subcellular localization of EVI1 is totally nuclear (Matsugi et al., 1990) . The localization of the PML-RARa protein, which is involved in t(15;17) promyelocytic acute myeloid leukemia, is known to depend on the leukemic or dierentiation-induced state of the cells. The protein is distributed as multiple microparticulates in the leukemic cells and is reorganized into structures named POD after retinoic acid treatment of the cells (Dyck et al., 1994; Weis et al., 1994) . This redistribution of PML-RARa occurs inside the nucleus. Thus, in contrast to other types of leukemic, chimera proteins, it is a unique property of PEBP2b/CBFb-SMMHC to have two distinct subcellular locations, namely the cytoplasm and the nucleus. When located in the cytoplasm, the chimeric protein would act as a kind of disorganizer of stress ®bers, whereas the nuclear located protein would deregulate transcription.
The PEBP2b/CBFb-SMMHC protein in the leukemic cell There has been no experimental evidence reported yet that the PEBP2b/CBFb-SMMHC chimeric protein has a cell transforming activity. Thus, it is not known either whether or how the dual functions of the Effect of PEBP2b-SMMHC on stress fibers and transcription Y Tanaka et al chimera as we observed in the present study is correlated with its putative oncogenic activity. It must be noted though that the membrane location of the chimera is not likely to be due to the artifact of its overexpression in tissue culture cells. This notion is based on the following observation. The ME-1 cell line is established from human leukemic cells carrying the chromosomal inversion 16 in one allele (Yanagisawa et al., 1991) . A predominant amount of the chimeric protein inside the ME-1 cells was recovered in the physically isolated membrane fraction, whereas a minor proportion of the chimera was in the nuclear fraction (unpublished results). Therefore, the dual functions of PEBP2b/CBFb-SMMHC may be applicable to the inv 16-leukemic cells as well. It will be important in the future to describe in molecular terms how the distinct subcellular locations and dual functions of the chimeric protein actually contribute to leukemogenesis.
Materials and methods
Cell culture and cDNA transfection
The C2C12 mouse myoblasts were maintained in Dulbecco modi®ed Eagle medium supplemented with 20% (vol/vol) fetal calf serum in collagen coated dishes. The other cell lines were P19, NIH3T3 and REF52 cells. DNA transfection was performed by the calcium phosphate coprecipitation method, as modi®ed by Chen and Okayama (1987) . Four or twenty mg DNA was used for cells grown in 3 or 10 cm-diameter dishes. Fifteen hours after seeding, the cells were transfected with plasmid DNAs and placed in a 3% (vol/vol) CO 2 /air incubator for 14 h. The cells were rinsed with the media, returned to a 5% (vol/vol) CO 2 /air incubator and incubated further for 8 h. The cells were then processed for immunocytochemical or immunoblot analysis.
Plasmids
The expression plasmids, pEF-b2, pCX2neoaB1 and pEFb/MYH11, which express the b2 isoform of PEBP2b/ CBFb, the AML1b/PEBP2aB1 protein or the chimeric PEBP2b/CBFb-SMMHC protein, respectively, were described previously (Lu et al., 1995; Sakakura et al., 1994) . pEF-AML1/MTG harbors a cDNA encoding a long form of the AML1-MTG8 protein . The HA-tag representing an epitope of¯uvirus hemagglutinin was fused to the aminoterminus of PEBP2b/ CBFb-SMMHC by the PCR method as follows. PCR was performed on a template DNA of pEF-b/MYH11 using a sense primer, 5'-ccggaattcatgtatccatatgatgttccagattatgctatgccgcgcgtcgtgccc-3' and an antisense primer, 5'-ccggaattctcactgcgaagtttcctg-3'. The singly and doubly underlined sequences in the sense primer represent the HA epitope and the codon of the initiating methionine of PEBP2b/CBFb, respectively, whereas the underlined sequence in the antisense primer represents the termination codon. The extreme 5' sequences in both primers harbor the EcoRI sites. The PCR product was subcloned into the EcoRI site of pCX2neo (Niwa et al., 1991) and the resulting plasmid was designated pCX2neoHA/b/MYH11. An internal deletion mutant, pCX2neoHA/Db/MYH11, that lacks a region spanning amino acid 5 ± 141 in the PEBP2b portion of the chimera was constructed by deleting a 411 base pair Bsp1286I/StuI fragment from the DNA of pCX2neoHA/b/MYH11. The Bsp1286I end was blunted. The modi®ed sequences in pCX2neoHA/b/ MYH11 and pCX2neoHA/Db/MYH11 were checked by the dideoxy-sequencing method. The reporter and reference plasmids used in the CAT assays were Tb3W4W-tkCAT (Ogawa et al., 1993b) and pRSV-bGAL, respectively.
Immunoblot analysis
Proteins were extracted from 5610 5 of C2C12 cells in a 10 cm diameter dish by the urea-Triton method as follows. The medium was aspirated and the cell monolayer was ®xed with 5 ml of 10% (wt/vol) trichloroacetic acid for 30 min on ice and scraped down into the solution. The cell pellet recovered by centrifugation was dissolved in 80 ml of 9M urea, 2% (vol/vol) TritonX-100 and 1% (wt/vol) dithiothreitol and centrifuged. The supernatant was then supplemented with 20 ml of 10% (wt/vol) lithium dodecylsulfate and 5 ml of 1 M Tris-HCl, pH 8.0 and sonicated. After centrifugation, 20 mg of supernatant protein was loaded and separated by electrophoresis on a 0.1% (wt/vol) SDS-8% or 12% (wt/vol) polyacrylamide gel. Transfer of the proteins from the gel onto the ®lter, the blocking reaction, incubation of the ®lter with the appropriate antibodies and visualization of the immunocomplexes using ABC kit and ECL detection reagents were as described previously . The primary antibody used was a 500-fold-diluted, anti-HA mouse monoclonal antibody (clone 12CA5, Boehringer Mannheim), whereas the secondary antibody was a 1000-fold-diluted, biotin-conjugated anti-mouse IgG antibody (Cappel Products). The anti-PEBP2b peptide antibody was described previously .
Immunocytochemistry
The C2C12 cells were seeded at a density of 0.8610 5 cells per 3 cm-diameter collagen-coated dish. After cDNA transfection, the cells were ®xed with 3.7% (wt/vol) formaldehyde in phosphate buered saline (PBS) for 20 min followed by permeabilization with 0.1% (vol/vol) NP-40 in PBS for 10 min. The primary antibody was a 500-fold-diluted, anti-HA mouse monoclonal antibody and the secondary antibody was a 200-fold-diluted, biotin-conjugated anti-mouse IgG antibody. The primary antibody used to detect the AML1-MTG8 protein was a 3000-folddiluted, anti-murine AML1b/PEBP2aB1 rabbit antiserum whose characteristics will be described elsewhere, whereas the secondary antibody was a 1000-fold-diluted, biotinconjugated anti-rabbit IgG goat antibody (Vector Laboratories). Incubation of the samples with the respective antibodies was for 30 min at 378C. Coupling of streptoavidin to biotin and the coloring reaction were performed as described previously . For double labeling, the primary solution was a mixture of a 500-fold-diluted, anti-HA mouse monoclonal antibody and 0.2 unit/ml of RITC-conjugated phalloidin (Molecular Probes, Inc.). The secondary solution was a 100-fold-diluted, FITC-conjugated anti-mouse IgG goat antibody (Organon Teknika Corp.). Coverslips were mounted on glass slides with buered glycerol medium and the cells were viewed with a confocal laser scanning microscope (LSM410, Zeiss).
Preparation of the cytosolic, membrane and nuclear fractions from the cells The C2C12 cells were seeded at a density of 5610 5 cells in a 10 cm-diameter dish. After cDNA transfection, the medium was aspirated and the cell monolayers were rinsed twice with PBS and scraped down into PBS. The cells from 15 dishes were pelleted down to a volume of 200 ml and added to 1000 ml of a buer containing 10 mM HEPES-KOH, pH 7.6, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol, 1 mM EDTA, 1 mM EGTA and 1 mM phenylmethylsulfonyl¯uoride. The cell suspension was homogenized by 20 strokes in a Dounce homogenizer and the mixture was centrifuged at 1000 g for 10 min at 48C. The pellet was saved as nuclear fraction and the supernatant was further centrifuged at 100 000 g for 60 min at 48C. The supernatant and pellet were saved as cytosolic and membrane fraction, respectively. The nuclear and membrane fractions were dissolved in 1000 ml of a ureaTritonX-100 buer. A procedure to prepare the cytoskeleton was as described previously . Brie¯y, the cells were treated for 30 s with a solution containing 0.1% (vol/vol) NP-40, 0.1 M piperazine-N, N'-bis [2-ethanesulfonic acid], pH 6.9, 2 M glycerol, 5 mM MgCl 2 and 2 mM EGTA.
CAT assays
The C2C12 or P19 cells were seeded at a density of 2610 5 cells per 6 cm-diameter dish. Fifteen hours after seeding, plasmid DNAs were transfected and the cells were incubated for 18 h. The cells were scraped into PBS and pelleted down by centrifugation. The cell pellet was suspended in 250 ml of 250 mM Tris-HCl, pH 7.8 and frozen and thawed three times. The supernatant obtained by centrifugation was processed for measuring the activities of chloramphenicol acetyltransferase (CAT) (Gorman et al., 1982) . The amouts of extract and the incubation time were within the linear range of the enzyme reaction. Transfections were repeated six times and representative results were presented as data. The plasmid DNAs were as follows; 2 mg of a Tb3W4W-tkCAT reporter, 1 mg of a pCX2neoaB1 activator, 6 mg of a pCX2neoHA/b/MYH11, pCX2neoHA/Db/MYH11 or pEF-AML1/MTG8 eector and 1 mg of a pRSV-bGAL reference plasmid. The total amount of DNA transfected was adjusted to 10 mg by supplementing with pCX2neo plasmid DNA. The reference plasmid was included to monitor the transfection eciency and CAT activities were corrected after comparison with those of b-galactosidase.
